Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial

• Published in: Reproductive health Vol. 18; no. 1; pp. 1 - 192
• Main Authors: Singata-Madliki, Mandisa, Lawrie, Theresa A., Balakrishna, Yusentha, d’Hellencourt, Florence Carayon-Lefebvre, Hofmeyr, G. Justus
• Format: Journal Article
• Language: English
• Published: London BioMed Central 29.09.2021; BMC
• Subjects: Birth control; Condoms; Contraception; Diaries; DMPA; HIV; Human immunodeficiency virus; Intrauterine device; Intrauterine devices; IUD; LNG implant; Menstruation; Reproductive health; Sexual behavior; Sexual intercourse; Womens health; South Africa
• ISSN: 1742-4755; 1742-4755
• DOI: 10.1186/s12978-021-01232-6

Abstract Background The ECHO trial randomised 7829 women to depot medroxyprogesterone acetate (DMPA-IM), the copper intrauterine device (IUD) and the levonorgestrel (LNG) implant (1:1:1) and found no clear difference in HIV incidence between these three groups. We have previously hypothesized that oligo-amenorrhoea induced by DMPA-IM may have a protective effect on HIV acquisition. The aim of this ancillary study was to assess the effects of DMPA-IM, the IUD and the LNG implant on menstrual symptoms and sexual behavior and to correlate these with HIV acquisition. Methods At the Effective Care Research Unit (ECRU) in South Africa, of 615 women already randomised to DMPA-IM, the copper IUD and the LNG implant (1:1:1) 552 agreed to participate. Participants completed a 28-day symptom and behavior diary following their one-month ECHO trial visit and returning it at their 3-month follow-up visit. HIV acquisition data were retrieved from ECHO trial records. Results Of 552 women enrolled on the ancillary study, 390 (70.6%) completed their daily diary; 130, 133, and 127 received DMPA-IM, IUD, and LNG implant, respectively. Thirty-three (5.9%) of these women acquired HIV. Women on the progestin-only contraceptives were more likely to experience amenorrhoea, as expected, and were less likely to have intra-menstrual coitus than IUD users (p < 0.001 for DMPA-IM vs IUD and p = 0.002 for implant vs IUD). Overall coital frequency was highest and condom usage lowest among DMPA-IM users. Intra-menstrual coitus correlated positively, and duration of menstruation correlated negatively, with HIV acquisition, although these effects were not statistically significant (p = 0.09 and p = 0.079, respectively). Conclusions Findings support the hypothesis that oligo-amenorrhoea and the associated reduced intra-menstrual coitus may mitigate the potential for an increased biological risk of HIV acquisition with DMPA-IM but more evidence is needed. Study registration number PACTR201706001651380